Reply to Zhang et al,Clinical Infectious Diseases

当前位置： X-MOL 学术 › Clin. Infect. Dis. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Reply to Zhang et al
Clinical Infectious Diseases ( IF 11.8 ) Pub Date : 2018-02-24 , DOI: 10.1093/cid/ciy164
Ye Ma ₁ , Zhihui Dou ₁ , Jennifer M McGoogan ₁ , Zunyou Wu ₁

Affiliation

To the Editor—Zhang and colleagues [1] have correctly observed that, in our study [2] recently published in Clinical Infectious Diseases, a considerable proportion of persons living with human immunodeficiency virus (HIV) (PLWH) who were receiving antiretroviral therapy (ART) had not undergone viral load (VL) testing for HIV. They further noted that inadequate VL testing in China needs to be addressed, and they underscored the importance of VL testing for both clinical monitoring of individuals and systemic monitoring of the National Free ART Program. We could not agree more. Timely and periodic VL testing for all PLWH receiving ART is essential if China is to achieve improved outcomes for individuals (ie, reduced morbidity and mortality rates) and communities (ie, reduced transmission), not to mention the UNAIDS 90-90-90 targets [3].

更新日期：2018-02-24

点击分享查看原文

点击收藏

公开下载

阅读更多本刊最新论文本刊介绍/投稿指南

全部期刊列表>>